Guido Fechner
Overview
Explore the profile of Guido Fechner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
259
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haas M, Kriegmair M, Breyer J, Sikic D, Wezel F, Roghmann F, et al.
BJU Int
. 2024 May;
134(5):755-762.
PMID: 38717014
Objective: To investigate and compare the performance of urinary cytology and the Xpert BC Monitor test in the detection of bladder cancer in various clinically significant patient cohorts, including patients...
2.
Flegar L, Huber J, Putz J, Thomas C, Apel H, Wullich B, et al.
World J Urol
. 2024 Apr;
42(1):239.
PMID: 38630278
Purpose: An abnormal lower urinary tract poses significant challenges for transplant surgeons. Besides the ureteral anastomosis to an ileal conduit, there are diverse complex reconstructive solutions. Due to its rarity,...
3.
Buttner T, Ellinger J, Fechner G, Hauser S, Cox A, Stein J, et al.
Urol Case Rep
. 2024 Feb;
53:102675.
PMID: 38404683
We report a case of a 24-year-old male with a history of kidney biopsy at young age due to chronic renal dysfunction and challenging hypertension, who presented with flank pain...
4.
Breyer J, Eckstein M, Sikic D, Wezel F, Roghmann F, Brehmer M, et al.
Sci Rep
. 2023 Sep;
13(1):15437.
PMID: 37723173
To determine whether Xpert bladder cancer monitor, a noninvasive PCR-based biomarker test, can predict the need for 2nd transurethral resection of the bladder (TURB) better than clinical assessment. Patients scheduled...
5.
Huneburg R, Aretz S, Buttner R, Daum S, Engel C, Fechner G, et al.
Z Gastroenterol
. 2019 Nov;
57(11):1309-1320.
PMID: 31739377
Introduction: Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome and accounts for ~3 % of all CRCs. This autosomal dominant disorder is caused by germline mutations in...
6.
Stein J, Muller S, Hauser S, Fechner G
Aktuelle Urol
. 2018 Oct;
50(3):268-273.
PMID: 30357763
Background: In 2008, Kälble et al. presented the "serosa-lined and tapered ileum" ("Fulda nipple") as a new continence mechanism of the modified MAINZ-Pouch-I. In accordance with the principle of Abol-Enein,...
7.
Stein J, Latz S, Ellinger J, Fechner G, Safi M, Krausewitz P, et al.
BMC Urol
. 2018 Mar;
18(1):21.
PMID: 29548319
Background: Renal fungal bezoars are remarkably rare and mostly occur in immunodeficient patients. Only a small number of cases with immunocompetent patients have been published so far. The published treatment...
8.
Latz S, Hauser S, Muller S, Fechner G
Urol J
. 2014 May;
11(2):1442-6.
PMID: 24807757
Purpose: To evaluate individually tailored open nephron-sparing surgical techniques for urothelial carcinoma of the pyelocalyceal system (UCPCS). Materials And Methods: Four patients underwent nephron-sparing surgery for UCPCS including, open partial...
9.
Kranz J, Anheuser P, Rausch S, Fechner G, Braun M, Muller S, et al.
Cent European J Urol
. 2014 Apr;
66(4):481-6.
PMID: 24757550
Introduction: We evaluated the success rate of continent vesicostomy using an ileal segment with seroserosally embedded, tapered ileum for bladder augmentation with continent stoma following bladder neck closure (BNC) for...
10.
Hauser S, Zahalka T, Fechner G, Muller S, Ellinger J
Anticancer Res
. 2013 Oct;
33(10):4651-6.
PMID: 24123044
Aim: No reliable biomarker for renal cell carcinoma (RCC) exists. The purpose of this study was to analyze the value of CpG island hypermethylation of cell-free (cf) circulating serum DNA...